We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04285671
Brief Title: Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer

First Submitted : February 25, 2020
First Submitted that Met QC Criteria : February 25, 2020
First Posted : February 26, 2020

Last Update Submitted that Met QC Criteria : January 5, 2023
Last Update Posted : January 6, 2023